The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Certain sleeping positions, such as side sleeping, may be beneficial for your health. Experts suggest that sleeping on your ...

Palisade Bio's PALI-2108 could be a game-changer for gut health with strong upside potential. Read here for an investment analysis of PALI stock.

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality compared with those not taking the drugs. The mortality benefit was statistically ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

Results of a study of about 8,000 Americans showed the Shield blood test found 83% of colon cancers and was 90% accurate in ruling them out. Results of a study of about 8,000 Americans showed the ...

Dear Dr. Roach: I am a 79-year-old female who is currently on biannual infusions for osteoporosis and high cholesterol. In 2018, I was diagnosed with Lynch syndrome with an MSH6 deviation. The genetic ...

Oct 29 (Reuters) - Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say. Analyzing data on more than 5.2 million adults hospitalized for ...